yoohoocthulhu

The drug is cheap...because it's unpatentable (as a molecule anyway) and is old enough that any patents would be expired anyway.

The marketing of autoinjectors has some legitimate public health value, but it's also a clear business strategy to get new drug prices for an ancient drug

I'd say that Theranos is so much of an outlier that it's failure won't really have a huge effect.

They weren't patenting nor licensing any exciting technology. They had no groundbreaking presentations of their technology. They had no experts in the field working at the company or on the board....

I mean, it's amazing they raised money to begin with

The diagnostics space is kind of screwed at the moment anyway by court rulings that have severely limited the patentability of diagnostics tests